Syncromune
Syncromune is a clinical stage biopharmaceutical dedicated to the development of better immunotherapies for metastatic solid tumors.
B2X
CEO
Crunchbase URL
Email Address
info@syncromune.com
Facebook URL
Founder
Investors
Latest Funding Round Date
December 23, 2024
Latest Funding Round Amount (USD)
100,000,000
Latest Funding Type
LinkedIn URL
Location
Number of Employees (Ranges)
11 – 50
Phone Number
+15187966110
Total Funding Amount (USD)
100,000,000
Twitter URL
Official Website
Find more companies like Syncromune
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.